China Traditional Chinese Medicine Holdings (CHIZF) Fair Value & Analysis
Healthcare · US · Market cap $1.1B
China Traditional Chinese Medicine Holdings
CHIZF · US
Fair value as of: Jul 15, 2026
From 16 valuation models · updated today
Fair value updated Jul 15, 2026 — revised from $0.9100 to $0.4700 (−48.4%) since Jun 24, 2026. Share price −25.5% over the past month.
Price vs Fair Value (12 months)
12‑month range $0.1631 – $0.3454 · fair‑value band $0.4300 – $0.5100 · the $0.1631 price screens below the $0.4700 fair value. As of Jul 15, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
China Traditional Chinese Medicine Holdings (CHIZF) currently trades at $0.1631, while our model-based Fair Value estimate is $0.4700 — implying the stock looks roughly 188.2% undervalued today. We read business quality at 42/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
Over the trailing twelve months, China Traditional Chinese Medicine Holdings generated revenue of $14.7B at a net margin of -2.3%. Revenue declined 10.4% year over year. It earns a return on equity of -2.0%. The balance sheet holds a net cash position of $1.6B. Fundamentals as of Jul 15, 2026
Our scenario range runs from $0.4300 (bear case) to $0.5100 (bull case); at $0.1631, the current price sits below that range. The share trades about 65% below its 52-week high, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -48% fair-value upside — at 188%, CHIZF screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 15, 2026. TTM = trailing twelve months.
About the company
China Traditional Chinese Medicine Holdings Co. Limited, an investment holding company, engages in the research and development, production, and sale of traditional Chinese medicine (TCM) and pharmaceutical products in the People's Republic of China, Hong Kong, and internationally. It operates through four segments: Yi Fang, Tian Jiang, Tong Ji Tang, and Medi-World. The company manufactures, manages, and sells concentrated TCM granules, and TCM health care products and decoction pieces, as well as TCM finished drugs. It also provides Chinese medical related healthcare solutions, including Chinese medical consultation and diagnosis, TCM physiotherapy, and prescription with concentrated TCM granules, TCM therapies, TCM decoction pieces, and TCM healthcare product through its offline medical institutions. In addition, the company is involved in the retail sale of pharmaceuticals and decoction pharmaceutical; trading of pharmaceutical products; investment of the TCM health industry; …
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
China Traditional Chinese Medicine Holdings reported revenue of $14.4B in FY2025 versus $19.1B in FY2021, a compound −6.8%/yr. Reported net income was −$333M in FY2025.
Is CHIZF fairly valued? → Check now
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate (as of Jul 15, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Jiangsu Hengrui Pharmaceuticals Co 1276 | HK$57.85 | HK$29.84 | -48% |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,786 | ₹991.46 | -44% |
| Zoetis Inc Z1TS34 | R$26.19 | R$26.01 | -1% |
| Hansoh Pharmaceutical Group 3692 | HK$32.56 | HK$15.58 | -52% |
| Divi's Laboratories Limited DIVISLAB | ₹6,623 | ₹1,461 | -78% |
| PharmaEssentia Corporation 6446 | 1,095 TWD | 365.87 TWD | -67% |
| Torrent Pharmaceuticals Limited TORNTPHARM | ₹4,421 | ₹1,504 | -66% |
| Cipla Limited CIPLA | ₹1,401 | ₹592.37 | -58% |
| Zydus Lifesciences Limited ZYDUSLIFE | ₹1,089 | ₹841.98 | -23% |
| Dr. Reddy's Laboratories Limited DRREDDY | ₹1,291 | ₹1,053 | -18% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is China Traditional Chinese Medicine Holdings (CHIZF) undervalued?
What is the fair value of CHIZF?
What is the quality score of CHIZF?
What is the revenue of China Traditional Chinese Medicine Holdings (CHIZF)?
What is the net profit margin of CHIZF?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Unlock the full China Traditional Chinese Medicine Holdings analysis — and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.